Ergomed Group looks forward to attending ESMO Congress 2024 in Barcelona, Spain between 13-17 September, 2024.

The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.

If you’re attending, be sure to stop by Ergomed’s Booth #657. Our expert team will be available to answer any questions you may have and discuss how Ergomed’s tailored oncology solutions, with a specialization in Head & Neck cancers, can provide optimal support for your clinical trials.

Whether you’re focused on patient recruitment strategies in oncology, navigating complex regulatory affairs, or ensuring seamless project management, Ergomed is dedicated to helping you overcome the unique challenges of oncology research, particularly in the area of Head & Neck cancers. Don’t miss this opportunity to learn more about how our specialized services can drive success in your oncology studies.

Meet our Team at #ESMO24!

Ergomed Vice President of Global Medical Affairs, Dusan Markovic, has co-authored an abstract titled: “Prognostic significance of diagnostic staging in treatment naïve, resectable locally advanced primary oral cavity squamous cell carcinoma for neoadjuvant Leukocyte Interleukin Injection immunotherapy.” This important study explores the potential of neoadjuvant immunotherapy in improving treatment outcomes for patients with advanced oral cavity squamous cell carcinoma. Make sure to attend the relevant sessions at the ESMO Congress to learn more about this breakthrough research and its implications for oncology treatment.

Colin Hayward, MD
Head, Medical Science
Dusan Markovic, MD
VP, Global Medical Affairs
Sonja Pons, RN
Director of Strategy, Oncology
Juliet Moritz
Senior VP, Strategic Solutions & Patient Centricity
Nikola Strumberger, MD
Senior VP, Commercial Operations
Antonia Schultze
Senior Director, Business Development
Olivija Sileike
Director, Business Development
Katarina Djogatovic
Senior PV Physician
Bojana Milasinovic
Associate Medical Director

We look forward to seeing you.

To maximize your visit, we encourage you to schedule a meeting with our oncology experts to discuss how Ergomed can support your clinical trials. Whether you need assistance with trial design, patient recruitment strategies, or regulatory compliance, our team is here to help you achieve success in your clinical research, particularly in the challenging field of oncology.